NCT03587987

Brief Summary

There is a complex physiological process involved in establishing regular breaths at birth. After initiation of the first breath, fluid is removed from the alveoli and enough pressure must be generated to inflate the lungs . Most newborns will establish spontaneous regular breathing sufficient to maintain the heart rate above 100 beats/min and to improve perfusion within 3 minutes of birth. According to the neonatal resuscitation programme (NRP), if heart rate is below 100 or there is persistence of apnoea or gasping after the initial steps of drying/stimulation and oropharyngeal suction, intervention is required . The main focus of neonatal resuscitation is effective ventilation to improve gas exchange and prevent respiratory failure. After birth, approximately 4% to 10% of term and late preterm newborns will receive help breathing with positive-pressure ventilation (PPV). Adequate mask ventilation is essential when providing breaths during neonatal resuscitation. However, this can be difficult, especially for less experienced staff and may be affected by inadequate seal of the mask, gas leaks and airway obstruction. In addition, trauma may be caused by the volumes being given during pressure controlled ventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

July 3, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 16, 2018

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2018

Completed
Last Updated

February 28, 2023

Status Verified

February 1, 2023

Enrollment Period

27 days

First QC Date

July 3, 2018

Last Update Submit

February 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Percentage difference in expired tidal volumes produced by rPAP versus Neopuff resuscitation devices during simulated resuscitation using neonatal mannequins

    1 minutre

Study Arms (2)

Neopuff

ACTIVE COMPARATOR

neopuff

Device: Neopff

r PAP

EXPERIMENTAL

rPap device

Device: rPap

Interventions

NeopffDEVICE

manual ventilation

Neopuff
rPapDEVICE

Manual ventilation

r PAP

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Neonatology consultants and NCHD's from CUMH
  • Participants must have completed Neonatal Resuscitation Programme (NRP)
  • Participants must be working as doctors in the area of neonatology

You may not qualify if:

  • Any history of cardiac or respiratory disorder
  • Physicians who are post-call

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCC

Cork, Ireland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 3, 2018

First Posted

July 16, 2018

Study Start

July 3, 2018

Primary Completion

July 30, 2018

Study Completion

August 30, 2018

Last Updated

February 28, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations